In lung cancer cells, propofol promotes apoptosis also via ERK1/2 via activation and upregulation of p53 (77), and decreases metastatic cell behaviors by inhibiting HIF-1α (78) and MMPs-2,-7 and -9 (79). This evidence concerns the gene HIF1A and lung carcinoma.